Sonia Arrison | Lobbying for Longevity Progress @ Vision Weekend USA 2025
•February 5, 2026
0
Why It Matters
A4LI’s lobbying accelerates regulatory acceptance of longevity therapies, unlocking investment and expanding patient access while establishing a replicable model for other breakthrough health fields.
Key Takeaways
- •A4LI created first bipartisan U.S. longevity science caucus.
- •Montana passed right‑to‑try law enabling experimental longevity therapies.
- •Effective lobbying relies on quiet influence, not public credit.
- •Board composition must blend policy expertise with scientific knowledge.
- •Grassroots outreach, like 70 volunteers meeting Congress, drives change.
Summary
The interview with Sonia Arrison at Vision Weekend USA 2025 focused on the Alliance for Longevity Initiatives (A4LI), a newly formed Washington‑based lobbying group dedicated to advancing longevity science through policy. Arrison, a former public‑policy professional turned venture investor, described how A4LI was born from a partnership with Dylan Livingston and the foresight community, and how it quickly moved from concept to action.
A4LI’s early wins include establishing America’s first bipartisan longevity science caucus, securing co‑chairs from both parties, and helping Montana pass a right‑to‑try statute that permits experimental longevity therapies after safety trials. The group is also drafting policy prescriptions, influencing candidates such as New Hampshire’s Brian Cole, and positioning other states like New York and California for similar reforms.
Arrison highlighted the importance of quiet, behind‑the‑scenes influence, noting, “the best way to be effective in Washington is to give good ideas to politicians and let them take credit.” She also credited the blend of policy expertise and scientific knowledge on the board, and recounted how 70 volunteers personally visited congressional offices, a tactic that proved surprisingly impactful.
The effort signals a turning point for the longevity sector: by normalizing regulatory pathways and building bipartisan support, A4LI is paving the way for faster market entry of anti‑aging therapies, attracting capital, and creating a template that other emerging technologies—such as neuro‑health—might emulate.
Original Description
Vision Weekends are our flagship conference series, bringing together leading scientists, entrepreneurs, funders, and policymakers to explore frontier science and technology and to imagine paths toward flourishing futures.
This playlist features seminars and fireside chats from Vision Weekend USA, held December 5–7, 2025 in the Bay Area. Join for big ideas at the cutting edge of science and technology, in-depth conversations with leading experts, curated one-on-one meetings, tech demos, unconference sessions, mentorship hours, and a $10k project pitch competition. Stay for the community and the experience: lab tours, satellite events, biohacking sessions, a cypherpunk party, and surprise moments across iconic Bay Area locations.
══════════════════════════════════════
About The Foresight Institute
The Foresight Institute is a research organization and non-profit that supports the development of high-impact technologies. Since our founding in 1986 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support. From molecular nanotechnology, to brain-computer interfaces, space exploration, cryptocommerce, and AI, Foresight gathers leading minds to advance research and accelerate progress.
We are entirely funded by your donations. If you enjoy what we do please consider donating through our donation page: https://foresight.org/donate/
0
Comments
Want to join the conversation?
Loading comments...